![]() |
Gil I. Wolfe, MD |
The study to be published August 11 (available online on August 10 at 5 p.m.) found that surgical removal of the thymus gland from patients with myasthenia gravis, a rare autoimmune disease that affects neuromuscular function, provides significant benefit in patients who do not have a chest tumor.
Myasthenia gravis (MG) results from an immune-mediated